Overview

Articulate Labs has developed wearable technology that turns everyday activity into on-the-go physical therapy and rehabilitation through muscle stimulation and machine learning. The first target market for this technology is the $5B knee treatment market. Here, our device (KneeStim) will enable mobile quadriceps strengthening and re-education for the 14M+ seeking conservative, cost- and time-efficient knee treatment. Company status: * Working prototype * Feasibility study conducted * Four patents issued; two pending * Independent market validation with likely prescribers * Regulatory pathway established * Reimbursement codes identified This device has not yet been cleared by the FDA for marketing, and all above statements are prospective.